alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
##### 



EXHIBIT 31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE REGISTRANT, PURSUANT TO 17 CFR
240.13a  14(a) OR 17 CFR 240.15d  14(a) I, Richard K. McClelland, certify that:  1.
    
    I have reviewed this quarterly report on Form 10-K of Dynamex Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue
statements of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to
the period covered by this report;3.
    
    Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all
material respects the financial condition, results of operations and
cash flows of Dynamex Inc. as of, and for, the periods presented in
this report.4.
    
    The registrants other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
we have:  a.
    
    Designed such controls and procedures, or caused such
disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during
the period in which this report is being prepared;b.
    
    Evaluated the effectiveness of the registrants
disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by
this report based on such evaluation, andc.
    
    Disclosed in this report any change in the
registrants internal control over financial reporting that
occurred during the registrants most recent fiscal quarter that
has materially affected, or is reasonably likely to materially
affect, the registrants internal control over financial
reporting;  5.
    
    The registrants other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the registrants auditors and the audit committee of
registrants board of directors;  a.
    
    All significant deficiencies and material weaknesses
in the design or operation of internal controls which could
adversely affect the registrants ability to record, process,
summarize and report financial information; and




---



##### 



b.
    
    Any fraud, whether or not material, that involves
management or other employees who have a significant role in the
registrants internal controls over financial reporting. Date: June 7, 2004 /s/ RICHARD K. McCLELLAND
Name: Richard K. McClelland
Title: President and Chief Executive Officer
----

| (1)         | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|-------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|

| (2)         | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| /s/   Edmund C. Reiter   | /s/   Richard P. Moberg              |
|-----------------------------------------|----------------------------------------------------------------------------------------------------------------------|
| President & Chief Executive Officer | Chief Financial Officer                                                                                              |
|                                    |                                                                                                                 |
|                                    |                                                                                                                 |
| Date:  October 29, 2010       | Date: October 29, 2010                                                                                               |
EXHIBIT 32.1



SPEEDCOM Wireless Corporation

CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the quarterly report of SPEEDCOM Wireless Corporation (SPEEDCOM) on Form 10-QSB for the period ending September 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the
Report), I, Mark Schaftlein, Chief Financial Officer of SPEEDCOM, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) The information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of SPEEDCOM.



|                                                                                            
|--------------------------------------------------------------------------------------------
|/s/    Mark Schaftlein                                                                      
|                                                                                            
|Mark Schaftlein Chief Financial Officer
and acting Chief Executive Officer November 11, 2003



32
<PAGE>



                                  EXHIBIT 32.2

Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
-----------------------------------------------------------------------

I, Joseph W. Pooler, Jr., the Chief Financial Officer of Pegasus Satellite
Communications, Inc., hereby certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that the Form 10-Q of Pegasus Satellite
Communications, Inc. for the quarterly period ended March 31, 2004 (the "March
31, 2004 Form 10-Q"), which this certification accompanies, fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934 (15 U.S.C. 78m or 78o(d)) and information contained in the March 31, 2004
Form 10-Q fairly presents, in all material respects, the financial condition and
results of operations of Pegasus Satellite Communications, Inc.

A signed original of this written statement required by Section 906 has been
provided to Pegasus Satellite Communications, Inc. and will be retained by
Pegasus Satellite Communications, Inc. and furnished to the Securities and
Exchange Commission or its staff upon request.


Dated: May 17, 2004

/s/ Joseph W. Pooler, Jr.
Joseph W. Pooler, Jr.
<TABLE> <S> <C>


<ARTICLE>                    5
<LEGEND>
</LEGEND>
<CIK>                    0001016130

<NAME>                   United Community Holdings, Inc.
<MULTIPLIER>                                           1
<CURRENCY>                                    US Dollars

<S>                      <C>

<PERIOD-TYPE>            3-MOS
<FISCAL-YEAR-END>                             DEC-31-2000
<PERIOD-START>                                JAN-01-2000
<PERIOD-END>                                  MAR-31-2000
<EXCHANGE-RATE>                                         1
<CASH>                                               1471
<SECURITIES>                                            0
<RECEIVABLES>                                       16816
<ALLOWANCES>                                       (12500)
<INVENTORY>                                             0
<CURRENT-ASSETS>                                   114973
<PP&E>                                            3053217
<DEPRECIATION>                                    (412124)
<TOTAL-ASSETS>                                    5636669
<CURRENT-LIABILITIES>                              460096
<BONDS>                                                 0
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                             0
<COMMON>                                               80
<OTHER-SE>                                         530589
<TOTAL-LIABILITY-AND-EQUITY>                      5636669
<SALES>                                             66322
<TOTAL-REVENUES>                                    66322
<CGS>                                               26108
<TOTAL-COSTS>                                      172197
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                  58592
<INCOME-PRETAX>                                   (130889)
<INCOME-TAX>                                            0
<INCOME-CONTINUING>                               (130889)
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                      (130889)
<EPS-BASIC>                                         (0.02)
<EPS-DILUTED>                                       (0.02)



</TABLE>
Order entered October 19 , 2017

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05

- 16

- 01136

- CR
ALBERT AYALA, Appellant

V.
THE STATE OF TEXAS, Appellee
On Appeal from the 292nd Judi cial District Court

Dallas County, Texas Trial Court Cause No. F14

- 70946

- V



### O RDER

The State’s exhibits 36 and 37 were filed October 18, 2017. In light of this, we VACATE that portion of our October 17, 2017 order that orders Peri
Wood not sit as a court r eporter

. We DIRECT the Clerk to send copies of this order to the Honorable Brandon Birmingham, Presiding Judge, 292nd Judicial District Court; to Peri Wood, official court reporter of the 292nd Judicial District Court; to the Dallas County Auditor’s Office ; and to all counsel for all parties.

/s/ ELIZABETH LANG

- MIERS PRESIDING JUSTICE
I 

112TH CONGRESS 

1ST SESSION H. R. 3183 

To amend title XXVII of the Public Health Service Act to exempt licensed 

independent insurance producer remuneration from the medical loss ratio. 

IN THE HOUSE OF REPRESENTATIVES 

OCTOBER 13, 2011 

Mr. YARMUTH introduced the following bill; which was referred to the 

Committee on Energy and Commerce 

A BILL 

To amend title XXVII of the Public Health Service Act 

to exempt licensed independent insurance producer remuneration from the medical loss ratio. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. EXEMPTING LICENSED INDEPENDENT INSUR4 ANCE PRODUCER REMUNERATION FROM THE 

5 MEDICAL LOSS RATIO. 

6 (a) IN GENERAL.—Section 2718 of the Public Health 

7 Service Act (42 U.S.C. 300gg et seq.), as inserted by sec8 tion 1001 and amended by section 10101(f) of the Patient 

9 Protection and Affordable Care Act (Public Law 111– 

10 148), is amended— 


jbell on DSK7SPTVN1PROD with BILLS
2 

•HR 3183 IH

1 (1) in subsection (a)(3), by inserting ‘‘, remu2 neration paid for licensed independent insurance 

3 producers,’’ after ‘‘State taxes’’; 

4 (2) in subsection (b)(1)(A), in the matter pre5 ceding clause (i), by inserting ‘‘, remuneration paid 

6 for licensed independent insurance producers,’’ after 

7 ‘‘State taxes’’; 

8 (3) in subsection (b)(1)(B), by inserting ‘‘, re9 muneration paid for licensed independent insurance 

10 producers,’’ after ‘‘State taxes’’; and 

11 (4) by adding at the end the following new sub12 section: 

13 ‘‘(f) INDEPENDENT INSURANCE PRODUCER, REMU14 NERATION DEFINED.—For purposes of this section: 

15 ‘‘(1) The term ‘independent insurance producer’ 

16 means an insurance agent or broker, insurance con17 sultant, benefit specialist, limited insurance rep18 resentative, and any other person required to be li19 censed under the laws of the particular State to sell, 

20 solicit, negotiate, service, effect, procure, renew or 

21 bind policies of insurance coverage or offer advice, 

22 counsel, opinions, or services related to insurance. 

23 ‘‘(2) The term ‘remuneration’ means compensa24 tion paid by or accrued from an insurance issuer or 

25 health plan for services rendered under contractual 


jbell on DSK7SPTVN1PROD with BILLS
3 

•HR 3183 IH

1 agreement which may include fees, commissions, or 

2 rebates.’’. 

3 (b) REGULATIONS.—Not later than 60 days after the 

4 date of the enactment of this Act, the Secretary of Health 

5 and Human Services shall amend any applicable regula6 tions so as to take the amendments made by subsection 

7 (a) into account. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Annual Report of Torrent Energy Corporation (the “Company”) on Form 10-KSB for the period ended March 31, 2005 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark Gustafson, the President, Chief Executive Officer, Acting Chief Financial Officer and Director (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)            the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)            the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date:  June 30, 2005.

 
| /s/ Mark Gustafson |
|--------------------|

Signature:  Mark Gustafson 
| Title:    President, Chief Executive Officer, |
|---------------------------------------------------------|

Acting Chief Financial Officer and Director 

(Principal Executive Officer, Principal Financial Officer 

and Principal Accounting Officer)
C OURT OF A PPEALS FOR THE
F IRST D ISTRICT OF T EXAS AT H OUSTON

O RDER

Appellate case name: John Matt Rembert v

. Alnoor Malick and Shelina Malick

Ap pellate case number: 01

- 1 2

- 0 1 0 8 6

- C V

Trial court case number: 20 09

- 03407

Trial court: 1 8 9 th District Court of Harris County

Appellant, John Matt Rembert, proceeding pro se , has filed a motion to dismiss the appeal and expedite the mandate. However, the motion does not include a certificate of service

, indicating that the motion was served on the parties to the appeal or their counsel

. See T EX

. R.

A PP

. P. 9.5(a) (requiring service of all documents)

, 9.5 (d) (requiring all documents to include proof of service in form of acknowledgement of service by person served or certificate of

service )

, 9.5 (e) (requiring certificate of service to state date and manner of service; name and address of each person served; and, if person served is party’s attorney, name of party represented by attorney). Fu rther, the motion does not include a certificate of conference, indicating that Rembert conferred or attempted to confer with the other parties to the appeal

about the merits of the motion. See T EX

. R. A PP

. P. 10.1(a)(5) (requiring motion to include

certif icate of conference) . Accordingly, we dismiss Rembert’s motion to dismiss the appeal and expedite the mandate.

Nevertheless, t he Court will consid er any future motion filed in compliance with the Texas Rules of Appellate Procedure.

It is so ORDERED.

Judge’s signature: /s/ Russell Lloyd

 Acting individually  Acting for the Court

Date: June 9, 2015
1

Opinion issued November 18, 2014

In The



## Court of Appeals For The 

## First District of Texas

———————————— NO. 01
- 14
- 00646
- CV

——————————— TAMB R IA LEE , Appellant

V. DANIEL LEON PETERSON AND MORGAN PETERSON, JR. , Appellee s

On Appeal from the 239th District Court Brazoria County, Texas Trial Court Cause No. 53927

MEMORANDUM OPINION Appellant , Tamb r ia Lee , has neither paid the required fees nor established indigence for purposes of appellate costs. See T EX
. R. A PP
. P. 5, 20.1 ; see also T EX
. G OV ’ T C ODE A NN
. § § 51.207, 51.941(a), 101.041 ( West 201 3 ); Order Regarding Fees Charged in Civil Cases in the Supreme Court and the Courts of Appeals and2

Before the Judicial Panel on Multidistrict Litigation, Misc. Docket No. 07

- 9138 (Tex. Aug. 28, 2007), reprin ted in T EX
. R. A PP
. P . app. A § B(1)

. Further, appellant ha s not paid or made arrangements to pay the fee fo r preparing the clerk’s record

. See T EX
. R. A PP
. P. 37.3(b)

. After being notified that this appeal was subject to dismissal, appellant did not adequately respond. See T EX
. R. A PP
. P. 5 ; 42.3 (b)

. We dismiss the appeal for nonpayment of all required fees and for want of prosecution . We dismiss any pending motions as moot

.

PER CURIAM Panel con sists of Justices Keyes, Higley, and Brown

.
# Presidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2018

# Memorandum for the Secretary of State

Pursuant to section 706(1) of the Foreign Relations Authorization Act, Fiscal Year 2003 (Public Law 107-228) (FRAA), I hereby identify the following countries as major drug transit and/or major illicit drug producing countries: Afghanistan, The Bahamas, Belize, Bolivia, Burma, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, India, Jamaica, Laos, Mexico, Nicaragua, Pakistan, Panama, Peru, and Venezuela.

A country's presence on the foregoing list is not necessarily a reflection of its government's counternarcotics efforts or level of cooperation with the United States. Consistent with the statutory definition of a major drug transit or drug producing country set forth in section 481(e)(2) and (5) of the Foreign Assistance Act of 1961, as amended (FAA), the reason major drug transit or illicit drug producing countries are placed on the list is the combination of geographic, commercial, and economic factors that allow drugs to transit or be produced, even if a government has carried out the most assiduous narcotics control law enforcement measures.

Pursuant to section 706(2)(A) of the FRAA, I hereby designate Bolivia and Venezuela as countries that have failed demonstrably during the previous 12 months to adhere to their obligations under international counternarcotics agreements, and to take the measures required by section 489(a)(1) of the FAA. Included with this determination are justifications for the designations of Bolivia and Venezuela, as required by section 706(2)(B) of the FRAA.

In addition, the United States Government seriously considered designating Colombia as a country that has failed demonstrably to adhere to its obligations under international counternarcotics agreements due to the extraordinary growth of coca cultivation and cocaine production over the past 3 years, including record cultivation during the last 12 months. Ultimately, Colombia is not designated because the Colombian National Police and Armed Forces are close law enforcement and security partners of the United States in the Western Hemisphere, they are improving interdiction efforts, and have restarted some eradication that they had significantly curtailed beginning in 2013. I will, however, keep this designation under section 706(2)(A) of the FRAA as an option, and expect Colombia to make significant progress in reducing coca cultivation and production of cocaine.

                    I have also determined, in accordance with provisions of section 706(3)(A) of the FRAA, that support for programs to aid the people of Venezuela are vital to the national interests of the United States.                          ( print page 45414)    

                    You are hereby authorized and directed to submit this designation, with its Bolivia and Venezuela memoranda of justification, under section 706 of the FRAA, to the Congress, and publish it in the                     *Federal Register.*

[FR Doc. 2017-21028

Billing code 4710-10-P
Exhibit 10.4





 Exhibit 10.4 

CONFIDENTIAL 
  

***Text Omitted and Filed Separately 

with the Securities and Exchange Commission. 

Confidential Treatment Requested 

Under 17 C.F.R. Sections 200.80(b)(4) 

and Rule 406 of the 

Securities Act of 1933, 
 as
amended. 
 CONFIDENTIAL 

Execution Copy 
 To 

Carlos M. Arruda 
 Sr Manager, Research Operations and 

Strategic Planning 
 Centocor, Inc. 

200 Great Valley Parkway 
 Mail Code: R-1-3 
 Malvern, Pennsylvania 19355 

USA 
 CONFIDENTIAL 

November 7, 2006 
 Re: First
amendment to the Amended and Restated Research and License Agreement (“Agreement”) effective as of December 22, 2004, between Centocor, Inc. (“CENTOCOR”) and MorphoSys
AG (“MORPHOSYS”), related to Appendix 1.33 and the transfer of new Ig expression vectors to CENTOCOR (“First Amendment”). 

Dear Mr. Arruda, 
 MORPHOSYS owns new lg
expression Vectors belonging to its pMORPH®2 family, (each, a “Vector”) and CENTOCOR has manifested its interest in having access to such Vectors under the Agreement.
MORPHOSYS agrees to give CENTOCOR access to such Vectors under the Agreement. 

  
 1/4 


 ***Confidential Treatment Requested 













 CONFIDENTIAL 
  

MORPHOSYS and CENTOCOR hereby agree to amend Appendix 1.33 (MORPHOSYS HuCAL GOLD Library) of the Agreement in order to add the Vectors to
MORPHOSYS Technology1, free of charge to CENTOCOR. Such amendment shall be effective as of the date of this letter as above mentioned, subject to CENTOCOR’s countersignature below. Appendix
1.33 of the Agreement shall be deleted and replaced in its entirety by the Appendix 1.33 attached to this First Amendment. 
  

1 Unless defined herein or clearly indicated
otherwise, each capital term appearing in this letter shall have the meaning set forth in the Agreement 

  
 2/4 


 ***Confidential Treatment Requested 













 CONFIDENTIAL 
  

If the foregoing terms are agreeable to CENTOCOR, please countersign and date this letter herebelow and return the original to MORPHOSYS. MORPHOSYS
shall, after receipt of such countersigned letter, transfer the Vectors to CENTOCOR, as further agreed upon between MORPHOSYS and CENTOCOR. 
 Best
regards, 
  

							
	 /s/ Dr. Elisabeth Thomassen-Wolf
	 		  	 /s/ Dr. Harald Watzka
	  	
				
	 Dr. Elisabeth Thomassen-Wolf
	 		  	 Dr. Harald Watzka
	  	
				
	 Manager, Alliance Management
	 		  	Director, Head of Alliance
Management	  	
				
	 MorphoSys AG
	 		  	 MorphoSys AG
	  	
				
	 Date:
	 		  	 Date:
	  	


  

									
	 By       /s/ [Illegible]
	 		 	 date
	 	 12/1/06
	 	
				
	 Title SrVP Discovery Research
	 		 		 	
					
	 Centocor, Inc.
	 		 		 		 	



  
 3/4 


 ***Confidential Treatment Requested 













 CONFIDENTIAL 
  

APPENDIX 1.33 
 MORPHOSYS HuCAL GOLD Library

 [...***...] 

  
 4/4 


 ***Confidential Treatment Requested